Bumper Offer - Urjas oil Just @ Rs. 1
Epilive 500 Tablet (15) is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Epilepsy. Epilive 500 Tablet (15) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Epilive 500 Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Epilive 500 Tablet (15) also has some side effects, the most common being Fatigue, Headache, Drowsiness. While these are the most often observed Epilive 500 Tablet (15) side effects, there are can be others also. These have been listed below. Usually, these side effects of Epilive 500 Tablet (15) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Epilive 500 Tablet (15)'s effect is Moderate during pregnancy and Mild for lactating mothers. Warnings related to Epilive 500 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Epilive 500 Tablet (15) contraindications section.
Additionally, Epilive 500 Tablet (15) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Epilive 500 Tablet (15) is not safe while driving, and is not addiction.
Epilive 500 Tablet (15) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Epilive 500 Tablet (15) is used -
Moderate
Mild
Common
Is the use of Epilive 500 Tablet (15) safe for pregnant women?
Epilive may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Epilive again without your doctor's advice.
Is the use of Epilive 500 Tablet (15) safe during breastfeeding?
Breastfeeding women can take Epilive as it bears very minor side effects for them.
What is the effect of Epilive 500 Tablet (15) on the Kidneys?
Very few cases of side effects of Epilive on kidney have been reported.
What is the effect of Epilive 500 Tablet (15) on the Liver?
Very few cases of side effects of Epilive on the liver have been reported.
What is the effect of Epilive 500 Tablet (15) on the Heart?
Using Epilive does not have any harmful effects on the heart.
Epilive 500 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Epilive 500 Tablet (15) unless your doctor advises you to do so -
Is this Epilive 500 Tablet (15) habit forming or addictive?
Forming a habit of Epilive 500 Tablet (15) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Epilive 500 Tablet (15), you should not drive or work on any heavy machine, as Epilive 500 Tablet (15) can make you drowsy.
Is it safe?
Yes, but consume Epilive 500 Tablet (15) only on doctor's advice.
Is it able to treat mental disorders?
Epilive 500 Tablet (15) has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Epilive 500 Tablet (15)
Taking Epilive 500 Tablet (15) with food does not harm your health.
Interaction between Alcohol and Epilive 500 Tablet (15)
Taking alcohol with Epilive 500 Tablet (15) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
